Pages that link to "Q54060047"
Jump to navigation
Jump to search
The following pages link to Androgen receptor mutations in prostate cancer. (Q54060047):
Displaying 50 items.
- PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle (Q24685775) (← links)
- Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells (Q24800710) (← links)
- Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells (Q24806811) (← links)
- Advances in genetics: widening our understanding of prostate cancer (Q26740628) (← links)
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development (Q27009424) (← links)
- Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor (Q27659041) (← links)
- Plexin-B1 mutations in prostate cancer (Q30480866) (← links)
- HE3235 inhibits growth of castration-resistant prostate cancer (Q30491204) (← links)
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant (Q30495758) (← links)
- Physical labeling of papillomavirus-infected, immortal, and cancerous cervical epithelial cells reveal surface changes at immortal stage (Q30543116) (← links)
- Spatial interactions and cooperation can change the speed of evolution of complex phenotypes (Q30585147) (← links)
- Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription (Q33292178) (← links)
- Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects (Q33382106) (← links)
- Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence (Q33579568) (← links)
- ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines (Q33593873) (← links)
- Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo. (Q33607836) (← links)
- Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H. (Q33717757) (← links)
- Redefining hormone resistance in prostate cancer (Q33903836) (← links)
- The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity (Q34189517) (← links)
- Enzalutamide, a second generation androgen receptor antagonist: development and clinical applications in prostate cancer (Q34323836) (← links)
- Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride. (Q34448181) (← links)
- CYP17A1 inhibitors in castration-resistant prostate cancer (Q34456638) (← links)
- Towards nonspecific detection of malignant cervical cells with fluorescent silica beads (Q34493383) (← links)
- Angiogenin as a Molecular Target for the Treatment of Prostate Cancer (Q35090356) (← links)
- Androgen receptor gene polymorphisms and alterations in prostate cancer: of humanized mice and men. (Q35281575) (← links)
- Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells (Q35382353) (← links)
- Androgens and prostate cancer (Q35571886) (← links)
- Hormones and prostate carcinogenesis: Androgens and estrogens (Q35687198) (← links)
- A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer. (Q35754996) (← links)
- IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor (Q35933129) (← links)
- Mechanisms of the development of androgen independence in prostate cancer (Q36072079) (← links)
- Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status (Q36130890) (← links)
- Genomic and epigenomic alterations in prostate cancer. (Q36374578) (← links)
- Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage (Q36587631) (← links)
- Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer (Q36934025) (← links)
- The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer (Q37074725) (← links)
- Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer. (Q37098796) (← links)
- RNA editing of androgen receptor gene transcripts in prostate cancer cells (Q37142544) (← links)
- Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer (Q37357108) (← links)
- The role of androgen receptor mutations in prostate cancer progression. (Q37590123) (← links)
- Androgen regulation of prostate cancer: Where are we now? (Q37836264) (← links)
- The changing therapeutic landscape of castration-resistant prostate cancer (Q37913983) (← links)
- Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer (Q37980116) (← links)
- The complexity of prostate cancer: genomic alterations and heterogeneity. (Q38058243) (← links)
- Adaptation or selection--mechanisms of castration-resistant prostate cancer (Q38068116) (← links)
- Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor (Q38078285) (← links)
- Synergistic action of image-guided radiotherapy and androgen deprivation therapy (Q38387844) (← links)
- Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide. (Q38754074) (← links)
- Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus (Q38844346) (← links)
- Androgen receptor variation affects prostate cancer progression and drug resistance (Q38977288) (← links)